KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme (CME) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Cme (CME) over the last 17 years, with Q3 2025 value amounting to $18.4 million.

  • Cme's Capital Expenditures fell 3825.5% to $18.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $77.2 million, marking a year-over-year decrease of 1286.68%. This contributed to the annual value of $94.0 million for FY2024, which is 2303.66% up from last year.
  • Cme's Capital Expenditures amounted to $18.4 million in Q3 2025, which was down 3825.5% from $18.4 million recorded in Q2 2025.
  • Cme's 5-year Capital Expenditures high stood at $39.7 million for Q2 2021, and its period low was $14.2 million during Q1 2025.
  • For the 5-year period, Cme's Capital Expenditures averaged around $23.1 million, with its median value being $20.8 million (2023).
  • In the last 5 years, Cme's Capital Expenditures plummeted by 6100.0% in 2021 and then skyrocketed by 4974.87% in 2024.
  • Quarter analysis of 5 years shows Cme's Capital Expenditures stood at $27.3 million in 2021, then fell by 10.62% to $24.4 million in 2022, then fell by 14.75% to $20.8 million in 2023, then rose by 25.96% to $26.2 million in 2024, then decreased by 29.77% to $18.4 million in 2025.
  • Its last three reported values are $18.4 million in Q3 2025, $18.4 million for Q2 2025, and $14.2 million during Q1 2025.